Hepatic safety of antibiotics used in primary care

Adverse Events with 4 Months of Rifampin Therapy or 9 Months of Isoniazid Therapy for Latent Tuberculosis Infection

(2013) Dick Menzies et al.   ANNALS OF INTERNAL MEDICINE

Genetic Polymorphisms of Cytochrome P450 and Glutathione S-transferase Associated with Antituberculosis Drug-induced Hepatotoxicity in Chinese Tuberculosis Patients

(2013) T Wang et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Azithromycin-induced liver injury: Table 1

(2010) Alissa M. Lockwood et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Clinical and Toxicodynamic Evidence that High-Dose Pyrazinamide Is Not More Hepatotoxic than the Low Doses Currently Used

(2010) J. G. Pasipanodya et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Drug-induced hepatic injury in children: a case/non-case study of suspected adverse drug reactions in VigiBase

(2010) Carmen Ferrajolo et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Safety of 3 Different Reintroduction Regimens of Antituberculosis Drugs after Development of Antituberculosis Treatment–Induced Hepatotoxicity

(2010) Surendra K. Sharma et al.   CLINICAL INFECTIOUS DISEASES

Prediction of Severe Adverse Drug Reactions Using Pharmacogenetic Biomarkers

(2010) Masahiro Tohkin et al.   Drug Metabolism and Pharmacokinetics

Drugs Associated with Hepatotoxicity and their Reporting Frequency of Liver Adverse Events in VigiBase™

(2010) Ayako Suzuki et al.   DRUG SAFETY

Causality assessment in drug-induced liver injury using a structured expert opinion process: Comparison to the Roussel-Uclaf causality assessment method

(2010) Don C. Rockey et al.   HEPATOLOGY

Role of polymorphic N-acetyl transferase2 and cytochrome P4502E1 gene in antituberculosis treatment-induced hepatitis

(2010) Purabi Deka Bose et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury

(2010) Peter T. Donaldson et al.   JOURNAL OF HEPATOLOGY

Antituberculosis drug-induced hepatotoxicity: a comparison between patients with and without human immunodeficiency virus seropositivity

(2010) Natalia Saldanha Magalhães Coca et al.   Revista da Sociedade Brasileira de Medicina Tropical

Rifampin Hepatotoxicity Associated With Treatment of Latent Tuberculosis Infection

(2009) Francis F. Fountain et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Safety of Fluoroquinolone Use in Patients with Hepatotoxicity Induced by Anti‐Tuberculosis Regimens

(2009) Chao‐Chi Ho et al.   CLINICAL INFECTIOUS DISEASES

4 Months of Rifampin Compared with 9 Months of Isoniazid for the Management of Latent Tuberculosis Infection: A Meta‐analysis and Cost‐Effectiveness Study That Focuses on Compliance and Liver Toxicity

(2009) Panayiotis D. Ziakas et al.   CLINICAL INFECTIOUS DISEASES

Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection

(2009) Miguel F. Carrascosa et al.   CLINICAL THERAPEUTICS

Drug-Induced Hepatotoxicity or Drug-Induced Liver Injury

(2009) Aaron J. Pugh et al.   Clinics in Liver Disease

Drug-induced liver injury: what was new in 2008?

(2009) Gordon Liss et al.   Expert Opinion on Drug Metabolism & Toxicology

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin

(2009) Ann K Daly et al.   NATURE GENETICS

Trovafloxacin Enhances TNF-Induced Inflammatory Stress and Cell Death Signaling and Reduces TNF Clearance in a Murine Model of Idiosyncratic Hepatotoxicity

(2009) Patrick J. Shaw et al.   TOXICOLOGICAL SCIENCES

The role of the hemostatic system in murine liver injury induced by coexposure to lipopolysaccharide and trovafloxacin, a drug with idiosyncratic liability

(2009) Patrick J. Shaw et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Hepatotoxicity of Pyrazinamide

(2008) Kwok C. Chang et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

In Vitro Metabolism of a Model Cyclopropylamine to Reactive Intermediate: Insights into Trovafloxacin-Induced Hepatotoxicity

(2008) Qin Sun et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases

(2008) Allen D. Brinker et al.   HEPATOLOGY

Using controlled clinical trials to learn more about acute drug-induced liver injury

(2008) Paul B. Watkins et al.   HEPATOLOGY

Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: Search for signals

(2008) Craig Lammert et al.   HEPATOLOGY

Biliary penetration and pharmacodynamic exposure of linezolid in liver transplant patients

(2008) F. Pea et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Cefdinir-Induced Hepatotoxicity: Potential Hazards of Inappropriate Antibiotic Use

(2008) Joy Chen et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Thrombocytopenia associated with chronic liver disease

(2008) Nezam Afdhal et al.   JOURNAL OF HEPATOLOGY

Industry concern over EU hepatotoxicity guidance

(2008) Bethan Hughes   NATURE REVIEWS DRUG DISCOVERY

Idiosyncratic drug hepatotoxicity: a 2008 update

(2008) Raúl J Andrade et al.   Expert Review of Clinical Pharmacology

Moxifloxacin: update and perspectives after 8 years of usage

(2008) Hartmut M Lode et al.   Expert Review of Respiratory Medicine

Antituberculosis drug-induced hepatotoxicity: Concise up-to-date review

(2007) Alma Tostmann et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY